Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 266 | 15 | 246 |
| Samples | 161 | 8 | 149 |
| Peptides | 123 | 8 | 115 |
Function
H1FOO · Histone H1.8
May play a key role in the control of gene expression during oogenesis and early embryogenesis, presumably through the perturbation of chromatin structure. Essential for meiotic maturation of germinal vesicle-stage oocytes. The somatic type linker histone H1c is rapidly replaced by H1oo in a donor nucleus transplanted into an oocyte. The greater mobility of H1oo as compared to H1c may contribute to this rapid replacement and increased instability of the embryonic chromatin structure. The rapid replacement of H1c with H1oo may play an important role in nuclear remodeling (By similarity)
Isoforms & Proteins
2 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 115 amino-acid changes on canonical ENST00000324382 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in H1FOO · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in H1FOO – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chronic Myelogenous Leukemia | 1/25 4% | 0/0 0% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 3/133 2% |
| Endometrial Carcinoma | 1/42 2% | 7/612 1% |
| Melanoma | 2/210 1% | 23/1899 1% |
| Hodgkins Lymphoma | 0/16 0% | 1/122 1% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 6/810 1% |
| Cervical Carcinoma | 0/35 0% | 3/422 1% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 17/2550 1% |
| Other Solid Cancers | 0/94 0% | 9/1515 1% |
| Non-Cancerous | 0/104 0% | 5/830 1% |
| Colorectal Carcinoma | 2/143 1% | 16/3239 0% |
| Small Cell Lung Carcinoma | 0/9 0% | 4/752 1% |
| Biliary Tract Carcinoma | 0/54 0% | 5/950 1% |
| Bladder Carcinoma | 0/58 0% | 5/956 1% |
| Osteosarcoma | 0/45 0% | 1/166 1% |
| Burkitts Lymphoma | 1/32 3% | 0/196 0% |
| Non-Small Cell Lung Carcinoma | 0/304 0% | 7/1390 0% |
| Other Sarcomas | 0/69 0% | 3/699 0% |
| Gastric Carcinoma | 0/74 0% | 7/1809 0% |
| Head and Neck Carcinoma | 0/85 0% | 5/1574 0% |
| Esophageal Carcinoma | 0/23 0% | 2/769 0% |
| Medulloblastoma | 0/0 0% | 1/450 0% |
| Glioma | 0/52 0% | 4/2127 0% |
| Thyroid Gland Carcinoma | 0/45 0% | 3/1592 0% |
| Hepatocellular Carcinoma | 0/46 0% | 4/2210 0% |
| Neuroendocrine Tumour | 0/154 0% | 1/577 0% |
| Pancreatic Carcinoma | 0/89 0% | 2/1611 0% |
| B-Cell Non-Hodgkins Lymphoma | 0/88 0% | 3/2534 0% |
| Prostate Carcinoma | 0/13 0% | 2/2105 0% |
| B-Lymphoblastic Leukemia | 1/55 2% | 1/2640 0% |
Mutation Distribution
Where H1FOO is mutated · all tissues, split by cell line vs tissue
How many mutations in H1FOO were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 3 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 266 mutations in H1FOO
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|